Craig A. Collard, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 3,689 shares at $10.49 ($39K) on 2022-05-13, disclosed to the SEC on 2022-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| OPNT | BUY | 2022-05-17 | $368K | — | Filing → |
| SRRA | BUY | 2021-11-24 | $622K | — | Filing → |
| OPNT | BUY | 2021-09-15 | $45K | — | Filing → |